Oxyntic gastric atrophy in Helicobacter pylori gastritis is distinct from autoimmune gastritis

Journal of Clinical Pathology

Volumn 69, Issue 8, 2016, Pages 677-685

  Venerito, Marino ^a   Varbanova, Mariya ^a   Röhl, Friedrich Wilhelm ^a   Reinhold, Dirk ^a   Frauenschläger, Katrin ^a   Jechorek, Doerthe ^a   Weigt, Jochen ^a   Link, Alexander ^a   Malfertheiner, Peter ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAGA PROTEIN; GASTRIN 17; INTRINSIC FACTOR; PEPSINOGEN I; PEPSINOGEN II; GASTRIN; PEPSINOGEN;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE GASTRITIS; CLINICAL ARTICLE; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MALE; MIDDLE AGED; OXYNTIC GASTRIC ATROPHY; PRIORITY JOURNAL; SEROLOGY; STOMACH ATROPHY; STOMACH BIOPSY; STOMACH PARIETAL CELL; ADOLESCENT; AGED; ATROPHY; BLOOD; IMMUNOLOGY; PATHOLOGY; PROSPECTIVE STUDY; STOMACH MUCOSA; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ATROPHY; AUTOIMMUNE DISEASES; FEMALE; GASTRIC MUCOSA; GASTRINS; GASTRITIS; HELICOBACTER INFECTIONS; HUMANS; MALE; MIDDLE AGED; PEPSINOGEN A; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84982918829     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2015-203405     Document Type: Article

References (29)

1. Rugge M, Correa P, Dixon MF, et al. Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther 2002;16:1249-59.
2. Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161-81.
3. Venerito M, Malfertheiner P. Preneoplastic conditions in the stomach: Always a point of no return? Dig Dis 2015;33:5-10.
4. Rugge M, Fassan M, Pizzi M, et al. Letter: gastric cancer and pernicious anaemia-often Helicobacter pylori in disguise. Aliment Pharmacol Ther 2013;37:764-5.
5. Negrini R, Savio A, Poiesi C, et al. Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology 1996;111:655-65.
6. Claeys D, Faller G, Appelmelk BJ, et al. The gastric H+,K+-ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy. Gastroenterology 1998;115:340-7.
7. Venerito M, Kohrs S, Wex T, et al. Helicobacter pylori infection and fundic gastric atrophy are not associated with esophageal squamous cell carcinoma: A case-control study. Eur J Gastroenterol Hepatol 2011;23:859-64.
8. Park JY, Lam-Himlin D, Vemulapalli R. Review of autoimmune metaplastic atrophic gastritis. Gastrointest Endosc 2013;77:284-92.
9. Neumann WL, Coss E, Rugge M, et al. Autoimmune atrophic gastritis-pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol 2013;10:529-41.
10. Agréus L, Kuipers EJ, Kupcinskas L, et al. Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers. Scand J Gastroenterol 2012;47:136-47.
11. Venerito M, Radönz M, Reschke K, et al. Autoimmune gastritis in autoimmune thyroid disease. Aliment Pharmacol Ther 2015;41:686-93.
12. McNicholl AG, Forné M, Barrio J, et al. Accuracy of GastroPanel for the diagnosis of atrophic gastritis. Eur J Gastroenterol Hepatol 2014;26:941-8.
13. Wex T, Venerito M, Kreutzer J, et al. Serological prevalence of Helicobacter pylori infection in Saxony-Anhalt, Germany, in 2010. Clin Vaccine Immunol 2011;18:2109-12.
14. Rugge M, Meggio A, Pennelli G, et al. Gastritis staging in clinical practice: The OLGA staging system. Gut 2007;56:631-6.
15. Ottesen M, Feldt-Rasmussen UF, Andersen J, et al. Pernicious anemia. A study of initial forms of the disease and diagnostic significance of determination of the intrinsic factor antibody and parietal cell antibody. Ugeskr Laeger. 1992;154:3758-62.
16. Centanni M, Marignani M, Gargano L, et al. Atrophic body gastritis in patients with autoimmune thyroid disease: An underdiagnosed association. Arch Intern Med 1999;159:1726-30.
17. Nakao E, Mitsunaga A, Hamano T, et al. Case report of rheumatoid arthritis associated with type A gastritis and Hashimoto thyroiditis. Nihon Shokakibyo Gakkai Zasshi 2010;107:1927-32.
18. Wakabayashi T, Ohno H, Hayakawa Y, et al. Primary biliary cirrhosis associated with type A gastritis and chronic thyroiditis. J Gastroenterol 1999;34:415-19.
19. Smyk DS, Koutsoumpas AL, Mytilinaiou MG, et al. Helicobacter pylori and autoimmune disease: cause or bystander. World J Gastroenterol 2014;20:613-29.
20. Vannella L, Lahner E, Osborn J, et al. Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis. Aliment Pharmacol Ther 2010;31:1042-50.
21. de Vries AC, van Grieken NC, Looman CW, et al. Gastric cancer risk in patients with premalignant gastric lesions: A nationwide cohort study in the Netherlands. Gastroenterology 2008;134:945-52.
22. Miki K, Ichinose M, Ishikawa KB, et al. Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer. Jpn J Cancer Res 1993;84:1086-90.
23. De Vries AC, Kuipers EJ. Epidemiology of premalignant gastric lesions: implications for the development of screening and surveillance strategies. Helicobacter 2007;12:22e31.
24. http://www.gastropanel.com/professionals/interpretation. Access on March 21st 2015.
25. Varis K, Kekki M, Härkönen M, et al. Serum pepsinogen I and serum gastrin in the screening of atrophic pangastritis with high risk of gastric cancer. Scand J Gastroenterol Suppl 1991;186:117-23.
26. Vannella L, Lahner E, Osborn J, et al. Systematic review: gastric cancer incidence in pernicious anaemia. Aliment Pharmacol Ther 2013;37:375-82.
27. Miki K. Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels-"ABC method". Proc Jpn Acad Ser B Phys Biol Sci 2011;87:405-14.
28. Watabe H, Mitsushima T, Yamaji Y, et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: A prospective endoscopic cohort study. Gut 2005;54:764-8.
29. Dinis-Ribeiro M, Areia M, de Vries AC, et al, European Society of Gastrointestinal Endoscopy; European Helicobacter Study Group; European Society of Pathology; Sociedade Portuguesa de Endoscopia Digestiva. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012;44:74-94.